CXCL16淘汰赛通过抑制H2-DM分子介导抗原呈现来抑制喘气道炎症
Ting-Ting Liu1,2,3,4, Zhi Zhang2, Jing Deng5
1Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Cell death discovery
|March 6, 2025
概括
在树突细胞上表达的CXCL16通过增强抗原呈现促进喘. 抑制CXCL16可降低呼吸道炎症和粘液,这表明它是潜在的喘治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
背景情况:
- 瘤坏死因子受体超级家族成员15 (TNFRSF15) 参与免疫调节.
- 树突细胞 (DCs) 在喘中对抗原呈现和T细胞原始化至关重要.
- 清除器受体SR-PSOX/CXCL16在DC功能和喘病原性中的作用尚未完全理解.
研究的目的:
- 研究跨膜清除体受体CXCL16在调节树状细胞表型和喘中的功能中的作用.
- 确定CXCL16对呼吸道炎症和抗原呈现在喘小鼠模型的影响.
主要方法:
- 利用免疫组织化学和流细胞测量来检测喘患者和小鼠的肺组织中的CXCL16表达.
- 产生了CXCL16淘汰赛小鼠,以评估其在阿斯伯吉勒斯诱导的喘模型中的作用.
- 进行了阿斯伯吉勒斯脉冲树突细胞 (DC) 的采用转移,以评估它们的炎症潜力.
- 采用RNA测序和流细胞测量来分析CXCL16淘汰对DC功能的影响,包括通过MHC II伴侣H2-DM和DC亚型分化进行抗原处理和呈现.
主要成果:
- 在喘患者和小鼠的肺部,CXCL16在DC上显著表达.
- 在小鼠喘模型中,CXCL16淘汰赛抑制了呼吸道炎症,粘液产生和高反应性.
- CXCL16+ DCs促进了气道炎症,而CXCL16-DCs在收养转移时抑制了它.
- 通过降低H2-DM表达的调节和抑制对cDC2b亚型的分化,CXCL16淘汰赛损害了DC抗原的处理和呈现.
结论:
- 通过增强树突细胞抗原的处理和呈现,CXCL16在促进喘方面发挥着关键作用.
- 下调H2-DM表达和改变DC分化是CXCL16影响呼吸道炎症的关键机制.
- 准CXCL16为控制喘提供了一个潜在的治疗策略.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
211
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
211
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
314
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
314
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
190
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
190
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
333
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
333